959
Views
0
CrossRef citations to date
0
Altmetric
Review

Matrix metalloproteinases in COVID-19: underlying significance

, & ORCID Icon
Pages 295-301 | Received 31 Oct 2022, Accepted 27 Feb 2023, Published online: 10 Mar 2023

References

  • Liu KS, Mao XD, Ni W, et al. Laboratory detection of SARS-CoV-2: a review of the current literature and future perspectives. Heliyon. 2022;8(10):e10858.
  • da Silva-Neto PV, do Valle VB, Fuzo CA, On Behalf Of The Immunocovid Study Group, et al. Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress. Biomolecules. 2022;12(5):604.
  • Gelzo M, Cacciapuoti S, Pinchera B, et al. Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients. Sci Rep. 2022;12(1):1212.
  • Davey A, McAuley DF, O'Kane CM. Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair. Eur Respir J. 2011;38(4):959–970.
  • George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8(8):807–815.
  • Cevik M, Kuppalli K, Kindrachuk J, et al. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020;371:m3862.
  • Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J. 2020;55(4):2000607.
  • Anoop UR, Verma K. Pulmonary edema in COVID19 – a neural hypothesis. ACS Chem Neurosci. 2020;11(14):2048–2050.
  • Laronha H, Caldeira J. Structure and function of human matrix metalloproteinases. Cells. 2020;9(5):1076.
  • Cerofolini L, Fragai M, Luchinat C. Mechanism and inhibition of matrix metalloproteinases. CMC. 2019;26(15):2609–2633.
  • Kapoor C, Vaidya S, Wadhwan V, Hitesh, et al. Seesaw of matrix metalloproteinases (MMPs). J Cancer Res Ther. 2016;12(1):28–35.
  • Cui N, Hu M, Khalil RA. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1–73.
  • Amălinei C, Căruntu ID, Giuşcă SE, et al. Matrix metalloproteinases involvement in pathologic conditions. Rom J Morphol Embryol. 2010;51(2):215–228.
  • Austin KM, Covic L, Kuliopulos A. Matrix metalloproteases and PAR1 activation. Blood. 2013;121(3):431–439.
  • Warner RL, Bhagavathula N, Nerusu KC, et al. Matrix metalloproteinases in acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro. Exp Mol Pathol. 2004;76(3):189–195.
  • Nerusu KC, Warner RL, Bhagavathula N, et al. Matrix metalloproteinase-3 (stromelysin-1) in acute inflammatory tissue injury. Exp Mol Pathol. 2007;83(2):169–176.
  • Vassiliou AG, Kotanidou A, Dimopoulou I, et al. Endothelial damage in acute respiratory distress syndrome. IJMS. 2020;21(22):8793.
  • Syed F, Li W, Relich RF, et al. Excessive matrix metalloproteinase-1 and hyperactivation of endothelial cells occurred in COVID-19 patients and were associated with the severity of COVID-19. J Infect Dis. 2021;224(1):60–69.
  • Kaner RJ, Ladetto JV, Singh R, et al. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol. 2000;22(6):657–664.
  • Nasr El-Din A, Ata KAE, Abdel-Gawad AR, et al. Impact of high serum levels of MMP-7, MMP-9, TGF-β and PDGF macrophage activation markers on severity of COVID-19 in obese-diabetic patients. Infect Drug Resist. 2021;14:4015–4025.
  • Oikonomidi S, Kostikas K, Tsilioni I, et al. Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications. CMC. 2009;16(10):1214–1228.
  • Elkington PT, Friedland JS. Matrix metalloproteinases in destructive pulmonary pathology. Thorax. 2006;61(3):259–266.
  • Gropper MA, Wiener-Kronish J. The epithelium in acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care. 2008;14(1):11–15.
  • Ohbayashi H. Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci. 2002;3(4):409–421.
  • Korpos E, Wu C, Sorokin L. Multiple roles of the extracellular matrix in inflammation. CPD. 2009;15(12):1349–1357.
  • Solun B, Shoenfeld Y. Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19. Med Drug Discov. 2020;7:100052.
  • Gipson TS, Bless NM, Shanley TP, et al. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury. J Immunol. 1999;162(6):3653–3662.
  • Bhutta MS, Gallo ES, Borenstein R. Multifaceted role of AMPK in viral infections. Cells. 2021;10(5):1118.
  • Hardy E, Fernandez-Patron C. Targeting MMP-regulation of inflammation to increase metabolic tolerance to COVID-19 pathologies: a hypothesis. Biomolecules. 2021;11(3):390.
  • Gordon DE, Jang GM, Bouhaddou M, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):459–468.
  • Carling D. AMPK signalling in health and disease. Curr Opin Cell Biol. 2017;45:31–37.
  • Steinberg GR, Michell BJ, van Denderen BJ, et al. Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab. 2006;4(6):465–474.
  • Hudson MP, Armstrong PW, Ruzyllo W, et al. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (prevention of myocardial infarction early remodeling) trial. J Am Coll Cardiol. 2006;48(1):15–20.
  • Kim JH, Suk MH, Yoon DW, et al. Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 2006;291(4):L580–L587.
  • Zhang H, Mao YF, Zhao Y, et al. Upregulation of matrix metalloproteinase-9 protects against sepsis-induced acute lung injury via promoting the release of soluble receptor for advanced glycation end products. Oxid Med Cell Longev. 2021;2021:8889313.
  • Doroszko A, Hurst TS, Polewicz D, et al. Effects of MMP-9 inhibition by doxycycline on proteome of lungs in high tidal volume mechanical ventilation-induced acute lung injury. Proteome Sci. 2010;8(1):3.
  • Muhs BE, Patel S, Yee H, et al. Inhibition of matrix metalloproteinases reduces local and distant organ injury following experimental acute pancreatitis. J Surg Res. 2003;109(2):110–117.
  • Keck T, Balcom JH, 4th, Fernández-del Castillo C, et al. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology. 2002;122(1):188–201.
  • McGuire JK, Li Q, Parks WC. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol. 2003;162(6):1831–1843.
  • O'Kane CM, McKeown SW, Perkins GD, et al. Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit Care Med. 2009;37(7):2242–2249.